In 2007, Purdue Pharmaceuticals agreed to a $19.5 million settlement with 26 states and Washington D.C. to resolve a lawsuit alleging Purdue's involvment in the opioid crisis. Purdue also pled guilty to federal charges that same year related to its misbranding of OxyContin, paying $634.5 million to resolve a probe by the U.S. Justice Department. Now, South Carolina has filed a new lawsuit against Purdue for continuing to engage in misleading marketing practices that it had agreed to stop in the 2007 settlement. Purdue denies the allegations and says it is committed to putting an end to the opioid crisis. South Carolina's Attorney General Alan Wilson stated that Purdue had engaged in telling doctors that patients cannot become addicted to opioids and that if they appeared to be addicted, they only needed more of the drug. The U.S. Centers for Disease Control and Prevention states that in 2015 alone, opioids played a part in over 33,000 deaths.
Other Reporting Source: This story is also covered in the Wednesday, August 16, 2017 issue of the Wall Street Journal on page A3. State Sues Drugmaker For Opioid Marketing by Sara Randazzo